Cat.#: ACPP-1469
| Despition | S100A8 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered clear colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg | inquiry |
| ACPP-1274 | Visfatin Blocking Peptide (AC1274) | 250 µg | inquiry |
| ACPP-1292 | Nkx2.2 Blocking Peptide (AC1292) | 250 µg | inquiry |
| ACPP-1276 | MAP3K4 Blocking Peptide (AC1276) | 250 µg | inquiry |
| ACPP-1608 | Human INHBC Protein (AC1608) | 2 µg | inquiry |
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1284 | Nkx2.2 Blocking Peptide (AC1284) | 250 µg | inquiry |
| ACPP-1537 | Human YY1 Protein (AC1537) | 5 µg | inquiry |
| ACPP-1664 | Human BLMH Protein (AC1664) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.